It was found that 2DG-PLGA-NPs may boost T-cell trafficking in the TME by reducing the generation of lactate by tumor cells and increase the production of IFN-γ and the uptake of glucose by CD8+ T cells. This evidence concerns the gene CD8A and neoplasm.